Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death
worldwide. Risk factors for HCC include chronic hepatitis B and hepatitis C, alcohol …

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death
worldwide. In the past decade, there have been improvements in non-drug therapies and …

Hepatocellular carcinoma is a leading cancer worldwide. Its incidence is increasing, and is
closely related to advanced liver disease. Cirrhosis represents the greatest risk factor for this …

The clinical course of cirrhosis is mostly determined by the progressive increase of portal
hypertension, hyperdynamic circulation, bacterial translocation and activation of systemic …

Background & Aims Overall survival (OS) is a composite clinical endpoint in hepatocellular
carcinoma (HCC) due to the mutual influence of cirrhosis and active malignancy in dictating …

Hepatocellular carcinoma is the most common type of malignant tumour in Asia. Treatment
is decided according to the staging system with information on tumour burden and liver …

Hepatocellular carcinoma (HCC) is a heterogeneous disease that remains highly prevalent
in many Asian countries and is the second most common cause of cancer‐related mortality …

Several staging systems for hepatocellular carcinoma (HCC) have been developed. The
Barcelona Clinic Liver Cancer staging system is considered the best in predicting survival …

Background: Hepatocellular carcinoma (HCC) is characterized by a poor prognosis and
accounts for the fourth common cause of cancer-related deaths. Recently, pyroptosis has …

Importance Antiviral therapy cannot erase hepatocellular carcinoma (HCC) risk in patients
with chronic hepatitis B, and it is not indicated for most hepatitis B virus (HBV) carriers …